American Journal on Addictions

Article	Citations
Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID‐19 Pandemic in China	321
Internet Addiction Increases in the General Population During COVID‐19: Evidence From China	98
Microinduction of Buprenorphine/Naloxone: A Review of the Literature	59
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone	56
Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs	41
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic	35
The Increasing Prevalence of Fentanyl: A Urinalysis‐Based Study Among Individuals With Opioid Use Disorder in New York City	24
Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets	22
Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study	21
Building Outreach and Diversity in the Field of Addictions	21
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China	20
Review Article: Anabolic‐Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review	19
Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists	18
Development and Feasibility Study of an Addiction‐Focused Phenotyping Assessment Battery	18
Substance use, depression, and loneliness among American veterans during the COVID‐19 pandemic	15
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings	15
Brief Report: The Impact of COVID‐19 on Emergency Department Overdose Diagnoses and County Overdose Deaths	13
Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults	13
Race, Ethnicity, and Clinical Features of Alcohol Use Disorder Among US Military Veterans: Results From the National Health and Resilience in Veterans Study	12
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program	12
Case Series: Cariprazine for treatment of methamphetamine use disorder	11
Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter?	11
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl	10
A Healthcare System‐Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions	10
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths	10

Alexithymia, Emotion‐Regulation Strategies, and Traumatic Experiences in Prenatally Cocaine‐Exposed Young Adults	9
Zonisamide as an Adjunctive Treatment to Cognitive Processing Therapy for Veterans With Posttraumatic Stress Disorder and Comorbid Alcohol Use Disorder: A Pilot Study	9
Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention	9
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex	8
Single‐use, co‐use, and polysubstance use of alcohol, tobacco, and cannabis in sexual minority and heterosexual females	7
Chronic Pain Among Patients With an Opioid Use Disorder	7
Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health	7
Women's and men's experiences in group therapy for substance use disorders: A qualitative analysis	6
Binge drinking and sexual risk behavior among US sexual and gender minority college students	6
Associations Between Self‐Reported and Biological Measures of Nicotine Consumption Among Young Adult Nondaily Cigarette Smokers	6
β‐Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use	6
Systematic review: Rates of psychopathology, substance misuse, and neuropsychological dysfunction among transitional age youth experiencing homelessness	6
A Comparison of Mental and Behavioral Health Risks Factors Associated With Current Dual Use of Electronic Cigarette and Conventional Tobacco Cigarettes With Exclusive Tobacco Cigarette Use and Nonuse	6
Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder	6
Cigarette, e‐cigarette, and dual use during the third trimester of pregnancy in a national sample of heterosexual and sexual minority women	5
The Efficacy of Combined Electroacupuncture and Auricular Pressure on Sleep Quality in Patients Receiving Methadone Maintenance Treatment	5
Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β‐Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders	5
	5
Reduced alcohol use in patients prescribed pioglitazone	5
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial	5
Clinical correlates of drug‐related dreams in opioid use disorder	5
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	5
Prevalence, correlates, and consequences of attention‐deficit/hyperactivity disorder in a clinical sample of adults with tramadol use in Egypt	5
Congenital syphilis prevention in the context of methamphetamine use and homelessness	5
A longitudinal study on the impact of Internet gaming disorder on self‐perceived health, academic performance, and social life of first‐year college students	5
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience	5
Alcohol Craving and Psychiatric Disorders Among Current Drinkers	5
Main and Interactive Effects of Nicotine Product Type on Sleep Health Among Dual Combustible and E‐Cigarette Users	5
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder	5
Characterizing autistic traits in treatment‐seeking young adults with substance use disorders	5
Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study	5
Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016‐2019	5
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	4
Cingulate Cortex Structural Alterations in Substance Use Disorder Psychiatric Inpatients	4
Systematic Review: Treatment for Addictive Disorder in Transplant Patients	4
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health	4
Nicotine Inhalation and Suicide: Clinical Correlates and Behavioral Mechanisms	4
Commentary: It Is Not About Supply, It Is About Demand: Why the Self‐Medication Hypotheses Is Still So Important	4
Alcohol use at the intersection of sexual orientation and gender identity in a representative sample of youth in Colorado	4
Addiction, Race, and the Structurally Vulnerable	4
Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students	4
A cross‐sectional study: Nitrous oxide abuse in Parisian medical students	4
Gender differences among persons entering medication treatment for opioid use disorder in the community	4
Factors associated with readmission to alcohol and opioid detoxification in the Alaska Interior	4
Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine‐related substance use disorder symptoms	4
Correlates of optimism among patients in substance use disorder inpatient treatment	4
Legalization of cannabis in Canada—Local media analysis	4
CME Posters (n = 64)	4
Assessing the quality of publicly available videos on MDMA‐assisted psychotherapy for PTSD	3
Substance use disorders and treatment in Asian American and Pacific Islander women: A scoping review	3

The association between adverse childhood experiences and treatment response for adults with alcohol and other drug use disorders	3
	3
Case Report: Buprenorphine—A Treatment for Psychological Pain and Suicidal Ideation?	3
Outcomes associated with once‐daily versus multiple‐daily dosing of buprenorphine/naloxone for opioid use disorder	3
Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder	3
Demographic, Behavioral, and Proximal Risk Factors for Gambling Disorder in the US Military	3
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O	3
Essential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion	3
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatment	3
Parental influences on tobacco use and likelihood of future use among sexual minority young adult men and women in the United States	3
Trends in substance use disorder diagnoses among Veterans, 2009–2019	3
A systematic review of virtual reality therapies for substance use disorders: Impact on secondary treatment outcomes	3
Systematic review and meta‐analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disorders	2
Brief Report: Rates of Fentanyl Use Among Psychiatric Emergency Room Patients	2
Illegal behaviors as a consequence of gambling disorder	2
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students	2
Age of gambling onset and resultant gambling behavior during young adulthood in the United States	2
Persistence of Operant Responding for Food After Prior Cocaine Exposure in Fischer 344 But Not Lewis Rats	2
Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder	2
Ketamine use in relation to depressive symptoms among high school seniors	2
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain	2
	2
Hazardous Alcohol Use, Impulsivity, and HIV‐Risk Behavior Among HIV‐Positive Russian Patients With a History of Injection Drug Use	2
Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial	2
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	2
Comprehensive analysis of discharge reasons from methadone outpatient treatment programs	2
Comparing substance use treatment initiation and retention between telehealth delivered during COVID‐19 and in‐person treatment pre‐COVID‐19	2
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts	2
Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies	2
Opioid use disorder at delivery hospitalization in the United States: 2012–2016	2
Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs	2
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study	2
Trajectories of prescription opioid and heroin use in adulthood	2
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting	2
Opioid use disorder and its association with self‐reported difficulties participating in social activities	2
Prescription Drug Monitoring Program: Access in the First Year	2
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic	2
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	2
Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome	2
	2
Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended‐release buprenorphine	1
Opioid Response Network	1
Factors associated with dual and polytobacco use among people in residential substance use disorder treatment	1
Barriers to recovery for medical professionals: Assessing financial support through a survey of Physician Health Programs	1
Issue Information ‐ Editorial Board	1
Educating the community about the opioid epidemic and medications for opioid use disorder	1
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial	1
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study	1
Sensitivity of health records for self‐reported nonfatal drug and alcohol overdose	1
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	1
Call for special issue 2023	1
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit	1
Tobacco/nicotine use among individuals using cannabis for therapeutic purposes	1
Daily cannabis use may cause cannabis‐induced hyperalgesia	1
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	1
Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients	1
Symposia, Case Conference, Medical Update, and Case Summaries	1
Extended‐release buprenorphine in pregnancy	1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting	1
Medication treatment for alcohol use disorder in special populations	1
Opioid use disorder in the active service: Implications for intervention	1
Advocacy and Public Policy Efforts of the American Academy of Addiction Psychiatry	1
	1
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users	1
Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use	1
Racial/ethnic discrimination, ADH1B*3, and coping‐motivated drinking among Black college students	1
	1
AAAP PIPs 2022	1
Methadone‐Assisted Opiate Withdrawal and Subsequent Heroin Abstinence: The Importance of Psychological Preparedness	1
Sleep disturbance in clients attending a specialist addiction clinic	1
Stand against stigma	1
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan	1
Brief Report: Predictors of Relapse for Patients With Dextromethorphan Dependence	1
A call for increased addiction psychiatrist engagement in medical student education	1
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program	1
Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California	1
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment	1
Conference Schedule	1
Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report	1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	1

	1
Concurrent Paper Sessions	1
Averting neonatal abstinence syndrome and treating addiction among rural, opioid‐using young women	1
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression	1
The Development of Fellowship Training in Addiction Psychiatry	1
	1
Addiction specialists' attitudes toward psychedelics: A National Survey	1
Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States	1
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?	1
Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population?	1
Issue Information	0
Call for special issue 2022	0
Renew Your AAAP Membership	0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder	0
Issue Information ‐ Editorial Board	0
Risk factors for poor progression of addictive internet use across different COVID‐19 periods in China	0
AAAP on‐demand educational activities	0
	0
Issue Information	0
Call for special issue 2023	0
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	0
Issue Information ‐ Editorial Board	0
Call for review papers 2022	0
2022 Self‐Assessment examination	0
Adult self‐reported childhood maltreatment types are associated with treatment satisfaction and alcohol relapse in patients with comorbid substance use and mental health disorders	0
Call for special issue 2023	0
AATT AAP on‐demand	0
2023 Reviewer List (n = 223)	0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US	0
Call for review papers 2023	0
AAAP Annual Meeting Save the Date	0
Pay for Performance and Treatment Outcome in Agonist Treatment for Opioid Use Disorder	0
Medication Management for Stimulant Use Disorder Webinar	0
Issue Information ‐ ToC	0
Women in Addiction Psychiatry: How Can Specialty Societies Play a Role in Closing the Gender Gap in Academic Medicine?	0
Stimulants PIP Ad	0
Is your AAAP membership expiring soon?	0
AAAPs Self‐Assessment Exam	0
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	0
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	0
Issue Information ‐ ToC	0
Issue Information ‐ ToC	0
Issue Information	0
Stimulants Performance in Practice	0
Stand against stigma	0
Call for special issue 2022	0
Issue Information ‐ Editorial Board	0
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs	0
2022: The Year in Review	0
AAAP Membership	0
Issue Information	0
PCSS 8‐Hour MAT Waiver Course for Medical Students	0
Associations between muscle‐building exercise and alcohol use behaviors among adolescent boys: Results from the 2019 Youth Risk Behavior Survey	0
Motivational Interviewing PIP	0
Issue Information ‐ Editorial Board	0
Cannabis Use PIP Ad	0
Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes	0
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine	0
Addiction Psychiatry Advanced Psychotherapy Curriculum	0
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder	0
Trends in cocaine use among United States females of reproductive age, 2005–2019	0
AAAP's Product Portal	0
Issue Information	0
Registration is Open for AAAP's 31st Annual Meeting and Scientific Symposium	0
	0
Call for review papers 2023	0
Is your AAAP Membership expiring this month?	0
Issue Information ‐ ToC	0
Retrieve your CME from AAAPs Annual Meeting AAAPs Self‐Assessment Examination 2020	0
Alcohol and cannabis dual use among Black adults: Associations with alcohol use, use‐related problems, and race‐based discrimination	0
	0
Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths	0
Self assessment ad (002)	0
AAAP's Annual Meeting and Scientific Symposium	0
Issue Information	0
Issue Information	0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder	0
AJA Stand Against Stigma	0
Call for Review Papers 2023	0
AAAP Annual meeting ad	0
Call for review papers 2023	0
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center	0
Become a AAAP Member	0
Issue Information	0
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	0
2024 Annual Meeting Posters	0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?	0
Call for Special Issue 2024	0
Treatment Goals and Alcohol Use Outcomes in Veterans With Comorbid Alcohol Dependence and Posttraumatic Stress Disorder	0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019	0
Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice	0
Call for review papers 2023	0
Issue Information ‐ ToC	0
Submit Your Case Conference Proposal	0
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	0